Baseline immune signature scores of peripheral blood predict outcome to checkpoint inhibitor therapy in cancer patients

被引：0
|
作者：
Hattenhauer, S. T. [1 ]
Mispelbaum, R. [1 ]
Held, S. A. E. [1 ]
Marques, Palma L. [1 ]
Brossart, P. [1 ]
Heine, A. [1 ]
机构：
[1] Univ Hosp Bonn, Dept Oncol Hematol Immune Oncol & Rheumatol, Bonn, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1112
引用
下载
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [31] Combination Immune Checkpoint Inhibitor Therapy is Associated With Increased Blood Pressure in Melanoma Patients
    Turker, Isik
    Sharma, Ananya
    Huang, Shi
    Johnson, Douglas B.
    Alexander, Matthew R.
    HYPERTENSION, 2023, 80 (03) : E43 - E45
  • [32] IMMUNE CHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH PREEXISTING SARCOIDOSIS
    Pundole, X.
    Lambotte, O.
    Ramos-Casals, M.
    Suarez-Almazor, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1221 - 1222
  • [33] Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease
    Johnson, Douglas B.
    Beckermann, Kathryn E.
    Wang, Daniel Y.
    ONCOLOGY-NEW YORK, 2018, 32 (04): : 190 - 194
  • [34] Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy
    Kifjak, Daria
    Hochmair, Maximilian
    Sobotka, Daniel
    Haug, Alexander R.
    Ambros, Raphael
    Prayer, Florian
    Heidinger, Benedikt H.
    Roehrich, Sebastian
    Milos, Ruxandra-Iulia
    Wadsak, Wolfgang
    Fuereder, Thorsten
    Krenbek, Dagmar
    Fazekas, Andreas
    Meilinger, Michael
    Mayerhoefer, Marius E.
    Langs, Georg
    Herold, Christian
    Prosch, Helmut
    Beer, Lucian
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 170
  • [35] Baseline blood DNA methylation-based immune profiles are associated with survival outcomes in head and neck cancer patients on immune checkpoint therapy
    Zhang, Ze
    Sehgal, Kartik
    Shirai, Keisuke
    Butler, Rondi
    Lee, Min Kyung
    Molinaro, Annette
    Wiencke, John
    Koestler, Devin
    Stolrow, Hannah
    Ramush, Geat
    Salas, Lucas
    Haddad, Robert
    Kelsey, Karl
    Christensen, Brock
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
  • [36] Combination of two distinct subsets of peripheral blood CD8+T cells from patients with NSCLC predicts response outcome to immune checkpoint inhibitor therapy
    Cho, J-H.
    Lee, S-W.
    Yun, J. S.
    Kim, H-O.
    Cho, H.
    Song, S. Y.
    Oh, I-J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S591 - S591
  • [37] Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies
    Hernandez, Carlos
    Arasanz, Hugo
    Chocarro, Luisa
    Bocanegra, Ana
    Zuazo, Miren
    Fernandez-Hinojal, Gonzalo
    Blanco, Ester
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [38] An oxidative stress biomarkers predict prognosis in gastric cancer patients receiving immune checkpoint inhibitor
    Deng, Guiming
    Sun, Hao
    Huang, Rong
    Pan, Hongming
    Zuo, Yanjiao
    Zhao, Ruihu
    Du, Zhongze
    Xue, Yingwei
    Song, Hongjiang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [39] Perioperative therapy in renal cancer in the era of immune checkpoint inhibitor therapy
    Kuusk, Teele
    Abu-Ghanem, Yasmin
    Mumtaz, Faiz
    Powles, Thomas
    Bex, Axel
    CURRENT OPINION IN UROLOGY, 2021, 31 (03) : 262 - 269
  • [40] Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
    Yang, Si
    Wu, Ying
    Deng, Yujiao
    Zhou, Linghui
    Yang, Pengtao
    Zheng, Yi
    Zhang, Dai
    Zhai, Zhen
    Li, Na
    Hao, Qian
    Song, Dingli
    Kang, Huafeng
    Dai, Zhijun
    ONCOIMMUNOLOGY, 2019, 8 (12):
12345